Bacil Pharma share news, announcements and annual reports
BSE: 524516Pharmaceuticals & BiotechnologySmall Cap
Bacil Pharma Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994
Last close ₹18.81up ₹0.41 (2.23%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹18.40.
30 Oct: open ₹18.50, high ₹18.99, low ₹18.40
52-week range of traded prices to 30 Oct 2026
₹10.65Low, 26 Aug 2026₹61.80High, 10 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹27 Cr3,172nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 1.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,126
Bacil Pharma board meetings
152 filed, newest first. Page 3 of 4.
Aug 2021
6 Aug · Board meeting
Meeting on 14 Aug 2021: quarterly results
Jun 2021
23 Jun · Board meeting
Meeting on 30 Jun 2021: audited results and quarterly results
Feb 2021
5 Feb · Board meeting
Meeting on 13 Feb 2021: quarterly results
Nov 2020
5 Nov · Board meeting
Meeting on 12 Nov 2020: quarterly results
Sep 2020
8 Sep · Board meeting
Meeting on 15 Sep 2020: quarterly results
Aug 2020
Jul 2020
27 Jul · Board meeting
Meeting on 30 Jul 2020: audited results
Feb 2020
3 Feb · Board meeting
Meeting on 8 Feb 2020: quarterly results
Nov 2019
14 Nov · Board meeting
1 Nov · Board meeting
Meeting on 14 Nov 2019: quarterly results
Aug 2019
30 Aug · Board meeting
6 Aug · Board meeting
Meeting on 14 Aug 2019: quarterly results
May 2019
14 May · Board meeting
Meeting on 22 May 2019: audited results
Mar 2019
29 Mar · Board meeting
27 Mar · Board meeting
Meeting on 29 Mar 2019
Feb 2019
5 Feb · Board meeting
Meeting on 14 Feb 2019: quarterly results
Nov 2018
Aug 2018
Sep 2017
13 Sep · Board meeting
1 Sep · Board meeting
Apr 2017
27 Apr · Board meeting
24 Apr · Board meeting
Aug 2016
May 2016
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has transacted the following : 1. The Board has approved ....
Feb 2016
12 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 12, 2016, inter alia, has approved the following business:- - Authorised ....
Jul 2015
Mar 2015
26 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 26, 2015, has decided the following: 1. The Company has initiated discussion ....
Aug 2014
28 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 28, 2014, has considered the following business: - The matter for appointment ....
Feb 2014
14 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 14, 2014, inter alia, have discussed that M/s. Purva Sharegistry (India) Pvt. ....14 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 14, 2014, inter alia, has transacted the following: 1. The Board confirm ....
Feb 2012
29 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 24, 2012, appointed Mr. Lalit Jain as Additional Director of the Company to ....